A diabetes breakthrough in search of patients

by Lisa Jarvis In a first, the U.S. Food and Drug Administration has approved a therapy that slows the onset of Type 1 diabetes. Teplizumab, developed by Provention Bio, typically del

You have reached content available exclusively to Dominion Post subscribers

Get unlimited premium access to The Dominion Post for only $10!

Subscribe Now or sign in to read the rest of this content.